Clinical Cancer Research Holland
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schleypen, J. S.
Right arrow Articles by Noessner, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schleypen, J. S.
Right arrow Articles by Noessner, E.
Clinical Cancer Research Vol. 12, 718-725, February 2006
© 2006 American Association for Cancer Research


Human Cancer Biology

Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma

Julia S. Schleypen1,2, Nicole Baur1, Robert Kammerer1,2, Peter J. Nelson3, Karl Rohrmann4, Elisabeth F. Gröne5, Markus Hohenfellner6, Axel Haferkamp6, Heike Pohla1,2, Dolores J. Schendel1, Christine S. Falk1 and Elfriede Noessner1

Authors' Affiliations: 1 Institute of Molecular Immunology, GSF National Research Center for Environment and Health; 2 Laboratory for Tumor Immunology, 3 Medizinische Poliklinik, and 4 Department of Urology, Ludwig-Maximilians-University, Munich, Germany; 5 Department of Cellular and Molecular Pathology, German Cancer Research Center (Deutsches Krebsforschungszentrum); and 6 Department of Urology, University Clinic Heidelberg, Heidelberg, Germany

Requests for reprints: Elfriede Noessner, Institute of Molecular Immunology, GSF Research Center for the Environment and Health, Marchioninistrasse 25, 81377 Munich, Germany. Phone: 49-89-7099303; Fax: 49-89-7099300; E-mail: noessner{at}gsf.de.

Purpose: Renal cell carcinoma harbors high numbers of infiltrating lymphocytes with apparent limited efficacy in tumor control. This study focused on the natural killer (NK) cells infiltrating renal cell carcinoma.

Experimental Design: Tumor-infiltrating lymphocytes (TIL) were isolated from renal cell carcinoma and analyzed for NK cell frequency and phenotype (n = 34). NK cells were enriched and tested for effector function.

Results: Two renal cell carcinoma subtypes were identified, one containing high (>20% of the lymphocyte population, n = 14), the other low (<20%, n = 20), NK cell numbers. NK cells of both groups were noncytolytic ex vivo but differed in CD16 and cytotoxic effector molecule expression as well as in their capacity to acquire cytotoxic activity: The majority of NK cells from tumors with high NK cell content (high NK-TIL) were CD16bright, whereas few CD16bright NK cells were found in tumors with low NK cell frequencies (low NK-TIL). The CD16 dichotomy correlated with different capacities to develop cytotoxicity after short-term activation with interleukin-2 ex vivo: Low NK-TIL remained noncytolytic against K562 and unresponsive to signals via the activating receptor NKp46 despite expression of receptor and adaptor molecules. In contrast, high NK-TIL acquired cytotoxic function. As described for peripheral CD16bright NK cells, NK cells from high-NK tumors showed high per cell expression of granzyme A, granzyme B, and perforin. NK cells from low NK-TIL resembled CD16neg/dim peripheral NK cells with few cytotoxin+ cells and lower expression of perforin.

Conclusion: The extent of NK cell infiltration and the expression of markers (CD16 and cytotoxins) predict the functional capacity of NK cells infiltrating renal cell carcinoma and can be used to characterize subgroups of renal cell carcinoma.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
R. Riesenberg, C. Weiler, O. Spring, M. Eder, A. Buchner, T. Popp, M. Castro, R. Kammerer, O. Takikawa, R. A. Hatz, et al.
Expression of Indoleamine 2,3-Dioxygenase in Tumor Endothelial Cells Correlates with Long-term Survival of Patients with Renal Cell Carcinoma
Clin. Cancer Res., December 1, 2007; 13(23): 6993 - 7002.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Wittnebel, S. Da Rocha, J. Giron-Michel, A. Jalil, P. Opolon, B. Escudier, P. Validire, K. Khawam, S. Chouaib, B. Azzarone, et al.
Membrane-Bound Interleukin (IL)-15 on Renal Tumor Cells Rescues Natural Killer Cells from IL-2 Starvation-Induced Apoptosis
Cancer Res., June 15, 2007; 67(12): 5594 - 5599.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Sconocchia, D. Del Principe, and A. J. Barrett
CD16low/negative Tumor-Infiltrating Lymphocyte: Lymphoid or Myeloid in Origin?
Clin. Cancer Res., March 1, 2007; 13(5): 1620 - 1620.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Noessner and J. S. Schleypen
The Complexity of Natural Killer Cells
Clin. Cancer Res., March 1, 2007; 13(5): 1621 - 1621.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.